| Unique ID issued by UMIN | UMIN000008846 |
|---|---|
| Receipt number | R000010370 |
| Scientific Title | Effect of dietary protein restriction on the progression of chronic kidney disease in patients with type 2 diabetes, a randomized controlled pilot study. |
| Date of disclosure of the study information | 2012/09/04 |
| Last modified on | 2016/03/04 10:31:51 |
Effect of dietary protein restriction on the progression of chronic kidney disease in patients with type 2 diabetes, a randomized controlled pilot study.
PROP-CKD study
Effect of dietary protein restriction on the progression of chronic kidney disease in patients with type 2 diabetes, a randomized controlled pilot study.
PROP-CKD study
| Japan |
Chronic Kidney Disease in patients with type 2 diabetes
| Endocrinology and Metabolism | Nephrology |
Others
NO
The purpose of this study is to investigate the effects of dietary protein restriction on the progression of chronic kidney disease in patients with type 2 diabetes.
Efficacy
Change of eGFR (estimated Glomerular Filtration Rate)
Body weight, Body mass index, Blood pressure, HbA1c, Observance rate, Food behavior modification, QOL at before and after dietary protein restriction.
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
Active
YES
YES
2
Educational,Counseling,Training
| Food | Behavior,custom |
Intensive nutrition education group.
We perform nutrition education once in two months after education hospitalization, and follow up until one year later.
Control group.
We perform nutrition education once in six months after education hospitalization, and follow up until one year later.
| 20 | years-old | <= |
| 80 | years-old | > |
Male and Female
1)Patients with type 2 diabetes.
2)Patients with non-dialysis-dependent chronic kidney disease ( eGFR < 60 ml/min/1.73m2 ).
3)Patients with the medical inspection of the chief physician.
4)Patients with the consent of the chief physician for this study.
5)Patients is willing to participate for this study.
6)Patients who agree to the purpose and contents of this study.
7)Patients who voluntary consent document was obtained.
8)Patients with education hospitalization.
9)Patients who perform dietary protein restriction for the first time.
1)Patients consent was not obtained for this study.
2)Patients who judged that the chief physician were not suitable for this study.
3)Patients who can not understand the contents of this study.
4)Patients having serious complications.
5)Patients having respiratory disease, and circulatory system disease.
80
| 1st name | |
| Middle name | |
| Last name | Shinobu Satoh |
Chigasaki Minicipal Hospital
Department of Endocrinology and Metabolism
5-15-1 Honson, Chigasaki-shi, Kanagawa, JAPAN
0467-52-1111
ushigome-k@kuhs.ac.jp
| 1st name | |
| Middle name | |
| Last name | Shinobu Satoh |
Chigasaki Minicipal Hospital
Department of Endocrinology and Metabolism
5-15-1 Honson, Chigasaki-shi, Kanagawa, JAPAN
0467-52-1111
ushigome-k@kuhs.ac.jp
Chigasaki Minicipal Hospital
None
Self funding
NO
茅ヶ崎市立病院(神奈川県)
| 2012 | Year | 09 | Month | 04 | Day |
Unpublished
No longer recruiting
| 2012 | Year | 07 | Month | 25 | Day |
| 2012 | Year | 09 | Month | 20 | Day |
| 2012 | Year | 09 | Month | 04 | Day |
| 2016 | Year | 03 | Month | 04 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000010370